Acciones Genomic Health, Inc.
Acciones
US37244C1018
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Kevin Conroy
CEO | Chief Executive Officer | 58 | 08/11/19 |
Jeffrey Elliott
DFI | Director of Finance/CFO | 46 | 08/11/19 |
D. Coward
SEC | Corporate Secretary | 59 | 08/11/19 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+1,51 % | 42,75 mil M | |
+49,22 % | 41,61 mil M | |
+8,57 % | 41,34 mil M | |
-12,36 % | 26,59 mil M | |
+8,92 % | 25,49 mil M | |
-25,13 % | 18,12 mil M | |
+29,17 % | 12,24 mil M | |
-3,12 % | 11,76 mil M | |
+6,35 % | 11 mil M |